Abstract

PurposeDifferentiating between diabetic nephropathy (DN) and non-diabetic renal disease (NDRD) is difficult and inefficient. The aim of the present study was to create a model for the differential diagnosis of DN and NDRD in patients with type 2 diabetes mellitus (T2DM).Patients and methodsWe consecutively screened 213 patients with T2DM complicated with chronic kidney disease, who underwent renal biopsy at The First Affiliated Hospital of Guangxi Medical University (Nanning, China) between 2011 and 2017. According to the pathological results derived from the renal biopsy, the patients were divided into three groups (74, 130, and nine in the DN, NDRD, and NDRD superimposed with DN group, respectively). Clinical and laboratory data were compared and a diagnostic model was developed based on the following logistic regression model: logit(P)=n{beta _0}n+n{beta _1}{X_1}n+n{beta _2}{X_2}n+ … +n{beta _m}{X_m}n.ResultsWe observed a high incidence of NDRD (61.0% of all patients), including various pathological types; the most common type was idiopathic membranous nephropathy. By comparing clinical variables, we identified a number of differences between DN and NDRD. Logistic regression analyses showed that the following variables were statistically significant: the absence of diabetic retinopathy (DR), proteinuria within the non-nephrotic range, the absence of anemia and an estimated glomerular filtration rate (eGFR) ≥90 mL/min/1.73 m2. We subsequently constructed a diagnostic model for predicting NDRD, as follows: PNDRD=1/[1+exp(−17.382–3.339×DR−1.274×Proteinuria−2.217×Anemia-1.853×eGFR−0.993×DM+20.892Bp)]. PNDRD refers to the probability of a diagnosis of NDRD (a PNDRD≥0.5 predicts NDRD while a PNDRD<0.5 predicts DN); while DM refers to the duration of diabetes. This model had a sensitivity of 95.4%, a specificity of 83.8%, and the area under the receiver operating characteristic curve was 0.925.ConclusionOur diagnostic model may facilitate the clinical differentiation of DN and NDRD, and assist physicians in developing more effective and rational criteria for kidney biopsy in patients with T2DM complicated with chronic kidney disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.